Phytochemical Fingerprinting and Multi‐Target Pharmacological Activities of Stoechospermum marginatum: Antioxidant, Antimicrobial, Antidiabetic and Neuromodulatory Potential
Abstract
ABSTRACT Despite growing interest in marine algae as reservoirs of bioactive compounds, the brown seaweed Stoechospermum marginatum remains largely unexplored. This study comprehensively investigated its phytochemical composition and evaluated its antioxidant, antimicrobial, anti‐diabetic, and neuroprotective potential. Chemical profiling via GC‐MS analysis identified twelve compounds in the n‐butanol extract, dominated by tetradecanoic acid (15.37%), whereas the dichloromethane (DCM) extract contained seven compounds, with pentadecanoic acid (33.78%) as the major constituent. The n‐butanol extract exhibited higher total flavonoid content (0.94 mg QE/g) than the DCM extract (0.17 mg QE/g). It also demonstrated superior antioxidant activity, with IC50 values of 7.00, 26.27, and 556 µg/mL against DPPH, ABTS+, and H2O2 radicals, respectively. The DCM extract showed stronger antibacterial activity against Enterococcus spp. and Escherichia coli, while the n‐butanol extract exhibited broader antimicrobial activity. Although the DCM extract displayed greater α‐amylase inhibition (IC50 = 54.03 µg/mL), the n‐butanol extract produced superior in vivo hypoglycemic effects. Furthermore, the DCM extract demonstrated significant anxiolytic and acetylcholinesterase inhibitory activities. Collectively, these findings highlight the therapeutic potential of S. marginatum extracts as multi‐target agents with antioxidant, antimicrobial, anti‐diabetic, and neuroprotective properties, supporting further exploration for pharmaceutical and nutraceutical applications.